how many people are on glp 1 Opportunities for nutrition brands in the GLP-1 boom Insights from Specialty Physicians on
Description
Patients with known allergies to probiotic ingredients, including dairy proteins or specific bacterial strains, should carefully review product labels
36 Following the switch, HbA 1c decreased from 7.46% 1.36% to 6.68% 1.00% ( P 30 mg/g) should preferably be treated with an SGLT2 inhibitor with evidence of reducing CKD progression, if eGFR is adequate
Treatment of type-2 diabetic patients with a combination of the DPP-4 inhibitor sitagliptin and liraglutide showed no greater efficacy on glucose control relative to treatment with liraglutide alone, potentially because of GLP-1R saturation by the liraglutide monotherapy [910]
If available, bioelectrical impedance analysis might provide additional information, though these measurements have limitations
